NIKKEI 225
38,837.55 +220.45 (+0.57%) HANG SENG
19,195.60 -25.02 (-0.13%) CRUDE OIL
77.16 -0.41 (-0.53%) GOLD FUTURES
2,383.30 -9.60 (-0.40%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,631.51 -500.82 (-0.91%)
STXS May 2024 5.000 put
| Previous close | 2.4400 |
| Open | 2.4400 |
| Bid | 2.7000 |
| Ask | 3.1000 |
| Strike | 5.00 |
| Expiry date | 2024-05-17 |
| Day's range | 2.4400 - 2.4400 |
| Contract range | N/A |
| Volume | |
| Open interest | 18 |
GlobeNewswireFirst Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology
ST. LOUIS, May 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy. Patients suffering from heart rhythm disorders are now being successfully treated with robotic ablation procedures using this advanced technology, and Hospital Santa Maria del
- GlobeNewswire
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024, scheduled to take place during Heart Rhythm Society Scientific Sessions this week in Boston, Massachusetts. Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-qualit
ZacksStereotaxis (STXS) Inks Deal to Buy Access Point Technologies
Stereotaxis' (STXS) deal to acquire electrophysiology catheter developer, Access Point Technologies, is likely to strengthen its position within the catheter market.
